Position in SPRY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,609,125
+$1,348,729 QoQ
Shares Held
1,699,017
+11.3% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 209 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. SPRY ranks #167 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SPRY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,609,125 | 1,699,017 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,260,396 | 1,526,824 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,090,934 | 1,552,870 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $15,131,450 | 1,505,617 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $23,424,652 | 1,342,387 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,856,800 | 1,260,477 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,062,545 | 1,238,156 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17,904,672 | 1,234,805 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,176,921 | 1,195,878 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $8,959,577 | 876,671 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,739,482 | 864,869 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,036,628 | 803,341 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,379,086 | 653,595 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,627,462 | 403,604 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,833,631 | 332,196 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,184,747 | 224,384 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $948,284 | 223,652 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,272,866 | 362,640 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,611,465 | 392,112 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,847,417 | 185,112 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,817,052 | 220,688 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,538,434 | 218,621 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $891,118 | 19,230 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||